Edition:
United States

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

29.09CNY
23 Oct 2018
Change (% chg)

¥-1.00 (-3.32%)
Prev Close
¥30.09
Open
¥30.09
Day's High
¥30.09
Day's Low
¥28.78
Volume
18,793,267
Avg. Vol
21,092,403
52-wk High
¥48.28
52-wk Low
¥26.51

Chart for

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood... (more)

Overall

Beta: 0.71
Market Cap(Mil.): ¥74,078.81
Shares Outstanding(Mil.): 2,563.06
Dividend: 0.38
Yield (%): 1.27

Financials

  600196.SS Industry Sector
P/E (TTM): 24.97 29.75 32.14
EPS (TTM): 1.20 -- --
ROI: 9.03 13.18 12.83
ROE: 11.93 15.14 14.95

UPDATE 1-China's Fosun Pharma stock tumbles after regulator's spot check on subsidiary

* Share price falls as much as 10 pct (Adds pictures to media information)

Aug 31 2018

China's Fosun Pharma stock tumbles after regulator's spot check on subsidiary

SHANGHAI, Aug 31 Shanghai Fosun Pharmaceutical Group Co Ltd saw its shares tumble by as much as 10 percent on Friday after it said regulators had made an unannounced inspection of a subsidiary prompted by a letter detailing alleged violations.

Aug 31 2018

BRIEF-Shanghai Fosun Pharmaceutical Group's Q1 Net Profit Down 4.33 Percent Y/Y

April 27 Shanghai Fosun Pharmaceutical Group Co Ltd:

Apr 27 2018

BRIEF-Shanghai Fosun Pharmaceutical Gets Approval To Issue Medium-Term Notes, Commercial Paper

April 24 Shanghai Fosun Pharmaceutical Group Co Ltd:

Apr 24 2018

Earnings vs. Estimates